Literature DB >> 3000589

Partial purification of transforming growth factors from human milk.

J A Zwiebel, M Bano, E Nexo, D S Salomon, W R Kidwell.   

Abstract

Crude, delipidated milk and the acid:ethanol extracts of primary human breast tumors contain several activities that biologically resemble transforming growth factors (TGFs) in that they promote the anchorage-independent growth of normal rat kidney and Mm5mt/c1 mouse mammary tumor cells in soft agar. Three major TGF species with isoelectric points (pl) of about 4.0, 6.0-6.5, and 7.0 have been detected in both tumors and milk. The pl 4.0 species from milk has been purified about 10,000-fold by isoelectric focusing and high-performance liquid chromatography. This species, designated milk-derived growth factor II (MDGFII), coelutes from gel filtration columns with an authentic human epidermal growth factor standard when using a low ionic strength eluting buffer. However, on the same column, MDGFII is completely resolved from human epidermal growth factor with high ionic strength eluting buffers. Nevertheless, MDGFII purified by the latter technique still competes with 125I-epidermal growth factor for receptor binding to A431 cell membranes. Additionally the TGF activity of MDGFII present in the pl 4.0 fraction of milk is markedly inhibited by anti-epidermal growth factor receptor antibody preparations. Consequently MDGFII appears to be an alpha-TGF. MDGFII is a pepsin-sensitive, disulfide reducing agent-sensitive, heat-stable protein that may be physiologically important for the mammary gland or the neonate.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3000589

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

Review 1.  EGF-related peptides in the pathophysiology of the mammary gland.

Authors:  N Normanno; F Ciardiello
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

2.  Transforming growth factor-beta (TGF-beta) in human milk.

Authors:  S Saito; M Yoshida; M Ichijo; S Ishizaka; T Tsujii
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

3.  Separation, purification, and sequence identification of TGF-beta 1 and TGF-beta 2 from bovine milk.

Authors:  Y Jin; D A Cox; R Knecht; F Raschdorf; N Cerletti
Journal:  J Protein Chem       Date:  1991-10

4.  Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats.

Authors:  Jonggun Kim; Hyung Kwan Kim; Saehun Kim; Ji-Young Imm; Kwang-Youn Whang
Journal:  J Med Food       Date:  2015-09-14       Impact factor: 2.786

5.  Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells.

Authors:  I Perroteau; D Salomon; M DeBortoli; W Kidwell; P Hazarika; R Pardue; J Dedman; J Tam
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

Review 6.  Epidermal growth factor-related peptides in the pathogenesis of human breast cancer.

Authors:  N Normanno; F Ciardiello; R Brandt; D S Salomon
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

Review 7.  Mitogenic regulation of normal and malignant breast epithelium.

Authors:  M E Lippman; R B Dickson
Journal:  Yale J Biol Med       Date:  1989 Sep-Oct
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.